This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Emoxypine
- DrugBank Accession Number
- DB19172
- Background
Emoxypine is under investigation in clinical trial NCT06221826 (MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for Emoxypine (DB19172)
- Weight
- Average: 137.182
Monoisotopic: 137.084063978 - Chemical Formula
- C8H11NO
- Synonyms
- 2-ethyl-3-hydroxy-6-methylpyridine
- 2-ethyl-6-methyl-3-hydroxypyridine
- 2-ethyl-6-methyl-3-pyridinol
- 3-pyridinol, 2-ethyl-6-methyl-
- 6-methyl-2-ethyl-3-hydroxypyridine
- Emoxipin
- Emoxipine
- Emoxypin
- Epigid
- Epygid
- Ethylmethylhydroxypyridine
- Methylethylpiridinol
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Product Ingredients
Ingredient UNII CAS InChI Key Emoxypine succinate 2R985002CT 127464-43-1 IKMNOGHPKNFPTK-UHFFFAOYSA-N
Categories
- Drug Categories
- Antiarrhythmic agents
- Antioxidants
- Antiplatelet agents
- Biological Factors
- Cardiovascular Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Compounds used in a research, industrial, or household setting
- Hematologic Agents
- Mutagens
- Noxae
- Protective Agents
- Psychotropic Drugs
- Pyridines
- Radiation-Protective Agents
- Toxic Actions
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- V247P5H4E1
- CAS number
- 2364-75-2
- InChI Key
- JPGDYIGSCHWQCC-UHFFFAOYSA-N
- InChI
- InChI=1S/C8H11NO/c1-3-7-8(10)5-4-6(2)9-7/h4-5,10H,3H2,1-2H3
- IUPAC Name
- SMILES
- CCC1=NC(C)=CC=C1O
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0245115
- ChemSpider
- 102688
- ChEMBL
- CHEMBL3338326
- ZINC
- ZINC000000036605
- Wikipedia
- Emoxypine
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data4 Completed Treatment Acute Ischemic Stroke 1 somestatus stop reason just information to hide 4 Completed Treatment Ocular Hypertension, Primary Open-angle Glaucoma (POAG) 1 somestatus stop reason just information to hide 3 Completed Treatment Ischemic Stroke 2 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 05, 2024 19:33 / Updated at July 06, 2024 06:53